Loading clinical trials...
Loading clinical trials...
MyOra® (Mycophenolate Mofetil) Post-Authorization Safety Study for Prophylaxis in de Novo Renal Transplant Patients
Conditions
Interventions
Mycophenolate Mofetil
Locations
1
Jordan
Prince Hamza Hospital
Amman, Jordan
Start Date
October 1, 2014
Primary Completion Date
September 1, 2016
Completion Date
September 1, 2016
Last Updated
May 8, 2018
Lead Sponsor
Hikma Pharmaceuticals LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions